Merck's drug "Vioxx" is taken off shelves

I guess you all heard it by now.

Merck was doing a study for Vioxx and its effect on colon polyps. During the study, the subjects started getting heart attacks and strokes.

So they decided to take it off shelves, as opposed to labelling it with a warning {as the FDA recomended?.

This all raises a lot of questions.
Like, how come this study group had so many heart attacks, and why are the general public on vioxx not having that many, or did they allready have a heart attack or stroke?

This is almost certainly related to something else, like vaccines, and the study group was chosen that way? This high rate of heart attacks and stroke while on Vioxx does not seem to be in the 'general public on Vioxx' at that high of a rate.

They could have shoved this under the rug too, it was their own study. Are they that worried about being sued for Vioxx causing heart attacks? Apparently. So where are the heart attacks? Or were they really worried about high death rates when patients on Vioxx take something else that triggeered the strokes? Something not yet on the market that they expect us all to use? Hmmmm


The related drug Celebrex is made of the same stuff. no word on it - {who makes it, anyone know?
Will they issue a statement? Keep posted.


Jawg